We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Accuses Amicus Therapeutics of Withholding Costly Branded Drug
Teva Accuses Amicus Therapeutics of Withholding Costly Branded Drug
Teva Pharmaceuticals has sued Amicus Therapeutics, alleging the company refused to supply samples of its high-priced branded drug, Galafold (migalastat), as required under federal law.